Dexcom (DXCM) FY2017 results: revenue $718 million, up 25.3% on the year
Dexcom Inc. (DXCM) reported revenue of $718 million for fiscal 2017, the year ended 31 December 2017, up 25.3% on the year before. Net income was -$50 million, and diluted earnings per share $-0.58. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2019.
Revenue
$718 million
+25.3% on the year
FY2010FY2017
Operating margin
-5.9%
-11.1% a year earlier
FY2010FY2017
Net income
-$50 million
FY2010FY2017
Diluted EPS
-$0.58
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
718
573
402
+25.3%
Cost of revenue
226
195
124
+16.2%
Gross profit
492
378
278
+30.0%
Gross margin
68.5%
66.0%
69.3%
Research and development
185
156
138
+18.8%
Selling, general and administrative
349
286
198
+22.0%
Operating income
-42.5
-63.9
-57.1
Operating margin
-5.9%
-11.1%
-14.2%
Interest expense
12.8
0.7
0.4
+1,728.6%
Pre-tax income
-48.6
-64.9
-57.5
Income tax
1.6
0.7
0.1
+128.6%
Net income
-50.2
-65.6
-57.6
Net margin
-7.0%
-11.4%
-14.3%
Diluted EPS
-$0.58
-$0.78
-$0.72
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
92.0
56.2
49.0
+63.7%
Capital expenditure
66.0
55.7
33.3
+18.5%
Free cash flow
26.0
0.5
15.7
+5,100.0%
Free cash flow margin
3.6%
0.1%
3.9%
Cash from investing
-144
-55.9
-51.5
Cash from financing
399
8.1
16.8
+4,827.2%
Depreciation and amortisation
16.1
15.0
10.8
+7.3%
Share-based compensation
106
111
82.7
-4.2%
Buybacks
0.0
0.0
n/a
Diluted shares, weighted
86m
n/a
n/a
Shares outstanding at period end
87m
85m
82m
+2.8%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
419
284
221
+47.8%
Debt
328
0.0
2.3
Other liabilities
157
119
68.5
+32.0%
Total liabilities and equity
904
403
292
+124.5%
Fixed assets
146
109
54.7
+33.1%
Goodwill
12.1
11.3
3.7
+7.1%
Intangible assets
n/a
0.2
2.2
Investments
122
35.1
29.1
+246.2%
Cash and equivalents
442
94.5
86.1
+367.2%
Receivables
134
102
74.1
+32.1%
Inventory
45.2
45.4
35.2
-0.4%
Other assets
3.9
5.2
6.9
-25.0%
Total assets
904
403
292
+124.5%
10-K for the year ended 31 December 2017, filed 21 February 2019: the filing.